| Name
|
RGD-targeted Proapoptotic Peptide
|
| Code
|
|
| The alias
|
RGD-targeted Proapoptotic Peptide
|
| Sequence (single letter abbreviation)
|
ACDCRGDCFC-GG-klaklakklaklak-NH2?(Disulfide Bridge Cys1-Cys4 and Cys2-Cys3)
|
| Sequence (three-letter abbreviation)
|
H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-Gly-DLys-DLeu-DAla-DLys-DLeu-DAla-DLys-DLys-DLeu-DAla-DLys-DLeu-DAla-DLys-NH2(trifluoroacetate salt)(Disulfide Bridge Cys1-Cys4 and Cys2-Cys3)
|
| A basic description
|
RGDS is a tetrapeptide that supports fibroblast attachment and inhibition of fibronectin binding to platelets.
|
| solubility
|
|
| The molecular weight
|
2707.4
|
| Chemical formula
|
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Lahdenranta, J. et al. FASEB J. 10.1096/fj.07-8273com (2007)
Ellerby, H. et al. Nat. Med. 5, 1032 (1999)
Smolarczyk, R. et al. Acta Biochim. Pol. 53, 801 (2006)
Curnis, F. et al. Cancer Res. 64, 565 (2004)
Su, Z. et al. Bioconjug. Chem. 13, 561 (2002).
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Disulfide Bridge Cys1-Cys4 and Cys2-Cys3)
|